As HIV Community Ages, Study Seeks to Address Inflammation
April 29, 2015
As the HIV community continues to thrive and get older, part of the focus shifts to ensuring that this population continues to do well by preventing inflammation and comorbidities. In 2011, people over age 55 accounted for 26% of the estimated 1.2 million people living with HIV in the U.S., according to the U.S. Centers for Disease Control and Prevention (CDC).
The AIDS Clinical Trial Group (ACTG) provided an update of its current study, "A5322 -- Long-term Follow-up of Older HIV-infected Adults: Addressing Aging, HIV Infection & Inflammation (HAILO)," in this month's ACTG newsletter.
According to the update:
The A5322 clinical team successfully enrolled approximately 1,000 HIV-positive participants aged 40 or older. These individuals are diverse in their cART [combination antiretroviral therapy] treatment experience, their co-morbid illnesses and their overall states of health. One extremely encouraging finding of this study has been how well-controlled HIV infection has remained for the vast majority of participants -- many of whom initiated cART more than 10-12 years ago. There is also an incredible amount of diversity in terms of co-morbid illnesses that are being treated simultaneously in these participants. It is important that illnesses (and their treatments) that are common among aging persons, such as hypertension, diabetes mellitus, and hyperlipidemia, are well-represented in this study.
The study is ongoing and will follow participants for seven years, and hopes to discover more on the relationships between HIV infection, age, the immune system and development of comorbidities.
Warren Tong is the senior science editor for TheBody.com and TheBodyPRO.com.
Follow Warren on Twitter: @WarrenAtTheBody.
Copyright © 2015 Remedy Health Media, LLC. All rights reserved.
This article was provided by TheBody.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.